Business Wire

FourKites Launches New Tools and Powerful Enhancements to Increase the Adoption of Supply Chain Visibility and Accelerate Time to Value

1.9.2021 11:00:00 EEST | Business Wire | Press release

Share

FourKites ®, the world’s leading real-time supply chain visibility platform, has released powerful new capabilities designed to help shippers, carriers and forwarders more quickly and easily collaborate to increase end customer satisfaction, reduce supply chain costs and increase on-time delivery performance. With ever-increasing demand, supply chain visibility has become table stakes for modern supply chains, and seamless connection and communication between carriers and shippers has never been more important. FourKites’ combination of swift carrier connections, powerful collaboration tools and the industry’s highest-quality real-time logistics data provides shippers and their forwarder/carrier partners with robust assurances of rapid, frictionless implementation and faster time to value.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210901005371/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

FourKites Launches New Tools and Powerful Enhancements to Increase the Adoption of Supply Chain Visibility and Accelerate Time to Value (Photo: Business Wire)

  • Instant Messenger, now with extended capabilities that allow shippers to chat directly with forwarders and carriers, gives supply chain partners the ability to view and share important information and resolve issues together, in real time. Without leaving the FourKites platform, track-and-trace and dispatch workers, drivers and warehouse personnel can view the critical information that affects shipments and deliveries — all in one single interface. Users can share documents, photographs and notes for any given load, as well as form online workgroups and control access as needed.
  • CarrierLink ®, the industry’s most downloaded visibility app for drivers, now includes improved turn-by-turn navigation for better route optimisation; mobile check-in; and new capabilities for updating appointment times, adding notes to loads and uploading paperwork. It also features enhanced capabilities for viewing fuel stops, weigh stations, location ratings and amenities along routes.

"We have hundreds of carriers within our network, from the courier side to the truckload side. When it comes to onboarding, FourKites has been fantastic,” said Josh Dolan, VP of Global Logistics, Cardinal Health. “They've done a phenomenal job working with carriers through the process and helping us fill the gap with new technologies that simplify and speed up onboarding, and enhance communication between Cardinal Health and our partners."

The German multinational Bayer saves time while increasing customer satisfaction thanks to FourKites’ supply chain visibility platform. The impact has already been so strong that the company has made visibility an essential part of its long term strategy.

“Every day, our carriers automatically share location data with our FourKites platform on hundreds of loads throughout Europe,” says Edmund Jager, Head of Distribution EMEA at Bayer. “We are able to track our products minute by minute and, in real time, pass on detailed arrival times to our customers. This means the distributors we supply always know their stock situation and end customers can depend on us to get them the seeds and crop protection they need, when they need them. We look forward to onboarding more carriers and so strengthen our customer-centric approach.”

In addition, FourKites recently announced its industry-first Tracking Quality Guarantee, which establishes the highest standards in supply chain data, guaranteeing real-time visibility and predictive intelligence into a minimum of 90% of customers’ shipments — end-to-end and across every mode and geography. This differentiated approach gives supply chain partners the collaborative opportunities and network effects they need to improve customer satisfaction and optimise their supply chain performance.

“As the first mover and leading innovator in real-time visibility and supply chain management solutions, FourKites is committed to helping shippers, forwarders and carriers achieve end-to-end supply chain visibility faster, and with assurances of the highest-quality tracking in the industry,” said FourKites founder and CEO Mathew Elenjickal. “We are excited to make these powerful new capabilities available to the community to enable greater collaboration and communication, and ultimately, value.”

About FourKites

FourKites® is the #1 supply chain visibility platform in the world, extending visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching 176 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 600 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Scott Johnston
European PR Lead for FourKites
+31 62 147 8442
scott.johnston@fourkites.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye